These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 38162558)
1. Use of Systemic Mycophenolate Mofetil Therapy in Ocular Surface Inflammatory Pathologies at the Initiative and Responsibility of the Ophthalmologist. Furundaoturan O; Akçay P; Selver OB Middle East Afr J Ophthalmol; 2022; 29(4):209-215. PubMed ID: 38162558 [TBL] [Abstract][Full Text] [Related]
2. Treatment of mucous membrane pemphigoid with mycophenolate mofetil. Nottage JM; Hammersmith KM; Murchison AP; Felipe AF; Penne R; Raber I Cornea; 2013 Jun; 32(6):810-5. PubMed ID: 23132447 [TBL] [Abstract][Full Text] [Related]
3. MMF and eye disease. Zierhut M; Stübiger N; Siepmann K; Deuter CM Lupus; 2005; 14 Suppl 1():s50-4. PubMed ID: 15803933 [TBL] [Abstract][Full Text] [Related]
4. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: three-year follow-up. The Mycophenolate Mofetil Acute Renal Rejection Study Group. Mycophenolate Mofetil Acute Renal Rejection Study Group Transplantation; 2001 Apr; 71(8):1091-7. PubMed ID: 11374408 [TBL] [Abstract][Full Text] [Related]
5. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: The Mycophenolate Mofetil Acute Renal Rejection Study Group. Transplantation; 1998 Jan; 65(2):235-41. PubMed ID: 9458021 [TBL] [Abstract][Full Text] [Related]
6. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group. Sollinger HW Transplantation; 1995 Aug; 60(3):225-32. PubMed ID: 7645033 [TBL] [Abstract][Full Text] [Related]
7. Systemic immunosuppression with mycophenolate mofetil to prevent corneal graft rejection after high-risk penetrating keratoplasty: a 2-year follow-up study. Szaflik JP; Major J; Izdebska J; Lao M; Szaflik J Graefes Arch Clin Exp Ophthalmol; 2016 Feb; 254(2):307-14. PubMed ID: 26553197 [TBL] [Abstract][Full Text] [Related]
8. Impact of mycophenolate mofetil on recurrent rejection in kidney transplant patients. Vasquez EM; Sifontis NM; Pollak R; Benedetti E Clin Transplant; 2001 Aug; 15(4):253-7. PubMed ID: 11683819 [TBL] [Abstract][Full Text] [Related]
9. Immunosuppressants for the prophylaxis of corneal graft rejection after penetrating keratoplasty. Abudou M; Wu T; Evans JR; Chen X Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007603. PubMed ID: 26313245 [TBL] [Abstract][Full Text] [Related]
10. The impact of routine mycophenolate mofetil drug monitoring on the treatment of cardiac allograft rejection. Yamani MH; Starling RC; Goormastic M; Van Lente F; Smedira N; McCarthy P; Young JB Transplantation; 2000 Jun; 69(11):2326-30. PubMed ID: 10868634 [TBL] [Abstract][Full Text] [Related]
11. Synergistic antiherpetic effect of acyclovir and mycophenolate mofetil following keratoplasty in patients with herpetic eye disease: first results of a randomised pilot study. Mayer K; Reinhard T; Reis A; Voiculescu A; Sundmacher R Graefes Arch Clin Exp Ophthalmol; 2003 Dec; 241(12):1051-4. PubMed ID: 12928902 [TBL] [Abstract][Full Text] [Related]
12. Long-term results of therapy with mycophenolate mofetil in ocular mucous membrane pemphigoid. Doycheva D; Deuter C; Blumenstock G; Stuebiger N; Zierhut M Ocul Immunol Inflamm; 2011 Dec; 19(6):431-8. PubMed ID: 22106912 [TBL] [Abstract][Full Text] [Related]
14. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. Transplantation; 1996 Apr; 61(7):1029-37. PubMed ID: 8623181 [TBL] [Abstract][Full Text] [Related]
15. Mycophenolate mofetil in the treatment of ocular inflammation in ANCA-associated vasculitis. Yalçindağ FN; Amer R; Forrester JV J Ocul Pharmacol Ther; 2008 Apr; 24(2):249-54. PubMed ID: 18321200 [TBL] [Abstract][Full Text] [Related]
16. Analysis of a single-center experience with mycophenolate mofetil based immunosuppression in renal transplantation. Triemer HL; Pearson TC; Odom KL; Larsen CP Clin Transplant; 2000 Aug; 14(4 Pt 2):413-20. PubMed ID: 10946781 [TBL] [Abstract][Full Text] [Related]
17. Mycophenolate mofetil versus cyclosporin A in high risk keratoplasty patients: a prospectively randomised clinical trial. Reis A; Reinhard T; Voiculescu A; Kutkuhn B; Godehardt E; Spelsberg H; Althaus C; Sundmacher R Br J Ophthalmol; 1999 Nov; 83(11):1268-71. PubMed ID: 10535855 [TBL] [Abstract][Full Text] [Related]
18. Increased incidence of allograft rejection in stable heart transplant recipients after late conversion from mycophenolate mofetil to azathioprine. Taylor DO; Sharma RC; Kfoury AG; Renlund DG Clin Transplant; 1999 Aug; 13(4):296-9. PubMed ID: 10485369 [TBL] [Abstract][Full Text] [Related]
19. A blinded, long-term, randomized multicenter study of mycophenolate mofetil in cadaveric renal transplantation: results at three years. Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. Mathew TH Transplantation; 1998 Jun; 65(11):1450-4. PubMed ID: 9645801 [TBL] [Abstract][Full Text] [Related]
20. Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The International Mycophenolate Mofetil Renal Transplant Study Groups. Halloran P; Mathew T; Tomlanovich S; Groth C; Hooftman L; Barker C Transplantation; 1997 Jan; 63(1):39-47. PubMed ID: 9000658 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]